search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
130 new news items in the last 24 hours
  1. Home
  2. International

Researchers in the USA are testing an experimental vaccine that could combat multiple types of cancer.

Ana Maria Eftene
whatsapp
facebook
linkedin
x
copy-link copy-link
5 December 2025, 10:01
main event image
International
Foto: Pexels.com
google-preference

Always see our news on Google

Researchers at the University of Amherst, Massachusetts, have developed an experimental vaccine based on nanoparticles that has demonstrated the ability to prevent several aggressive types of cancer, including melanoma, pancreatic cancer, and triple-negative breast cancer, in mice. The study showed that the vaccine maintained up to 88% of the animals without tumors, simultaneously activating multiple pathways of the immune system and generating strong T cell responses. This vaccine surpassed the performance of traditional formulations, which failed to protect animals from tumor development. The lead researcher, Prabhani Atukorale, emphasized the importance of the vaccine's ability to create systemic immune memory, allowing the body to recognize and destroy cancer cells in the long term. By using inactivated tumor cells, the vaccine was able to provide protection against multiple types of cancer without requiring customized genetic sequencing. The tumor rejection rate was 88% for pancreatic cancer, 75% for breast cancer, and 69% for melanoma.

Sources

sursa imagine
G4Media
Tot mai aproape de un vaccin universal împotriva cancerului
sursa imagine
Mediafax
Oamenii de știință sunt tot mai aproape de un vaccin universal împotriva cancerului

Latest News

18:19

Eurostat shows employment gaps of at least 18 percentage points between men and women in five regions of Romania

18:19

Two ANAF employees from Argeș were detained after allegedly asking for 40,000 lei to conceal tax irregularities

18:09

Police in Argeș found weapons, ammunition and pyrotechnic articles during 30 raids carried out in several localities

18:00

UniCredit pledges to keep Commerzbank’s headquarters and support German companies in order to gain control of the bank

17:49

Avocata generală a CJUE consideră că Facebook nu poate fi numit gratuit când accesul presupune folosirea comercială a datelor personale

See more news

NEWS ON THE SAME TOPICS

event image
Health
Moderna and Merck announce promising results for the personalized vaccine against melanoma recurrence
event image
International
Russia will use the CaTeVac vaccine from 2027 to treat sarcomas
event image
Health
The U.S. Food and Drug Administration has approved a drug that doubles the survival rate of patients with advanced pancreatic cancer.
event image
International
WCRF warns: Seven types of cancer have become more common in people under 50
event image
Health
Alzheimer’s drug tested on people without symptoms. Researchers want to find out whether the disease can be prevented
event image
Health
The pharmaceutical group Minapharm will develop a candidate vaccine against the Bundibugyo Ebola strain, with funding of 16.5 million dollars.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
Vaccine cancer prevent USA

Editor’s Recommendations

main event image
INSCOP Surveys
9 hours ago

November 2026: Informat.ro – INSCOP Research BAROMETER, 15th Edition – Chapter X: Temporary Restriction of Access to Online Platforms

main event image
Exclusive
1 hour ago

EXCLUSIVE Ranking of companies in relevant online sources in Romania: Nvidia dominates company visibility. Finance and investments lead the economic agenda

main event image
Opinions
7 hours ago

Andrei Pleșu: What Our Ministers Were and What They Have Become

main event image
Exclusive
8 hours ago

EXCLUSIVE The top domestic political topics trending over the past week / The Lyrica shortage crisis, Marian Neacșu’s new responsibilities, and debates over administrative reform

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol